Summit X’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
Other funds holding SER
Summit X's SER Position: Q1 2024 in Review
Summit X sold out of Serina Therapeutics (SER) in Q1 2024, closing a stake of 640 shares — an estimated $8.66K sold.
Summit X first reported a position in SER in Q2 2020 and held it in 14 quarters. The position peaked at $33K in Q1 2021. 13 funds tracked by Wall St. Rank hold SER as of Q1 2024.
- Summit X reported no remaining Serina Therapeutics position as of Q1 2024 after selling out during the quarter.
- Summit X sold 640 Serina Therapeutics shares in Q1 2024, an estimated $8.66K.
- Summit X first reported a position in Serina Therapeutics in Q2 2020 and held it in 14 quarters.
- Summit X's Serina Therapeutics position peaked at $33K in Q1 2021.
- 13 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2024.
Based on Summit X's 13F filing for Q1 2024, filed 8 May 2024.